FCVB 2024 Premium Access

The structural remodeling of the mitochondrial Ca2+ uniporter complex underlies its functional impairment during metabolic cardiomyopathy.

Congress Presentation

About the speaker

Doctor Mathieu Panel

Laboratory of Physiology and Experimental Medicine of Heart and Muscles (PhyMedExp), Montpellier (France)
0 follower

3 more presentations in this session

Innovative models for cardiotoxicity assessment in human pluripotent stem cell-derived cardiomyocytes that enable clinically relevant treatment regimen

Speaker: Assistant Professor V. Schwach (Enschede, NL)

Thumbnail

Prior cardiac ischemic injury exacerbates immune checkpoint inhibitor-induced cardiotoxicity

Speaker: Doctor T. Gergely (Budapest, HU)

Thumbnail

MicroRNA-mediated control of cardiac fibrosis: unraveling key players and mechanisms through functional genomics screenings

Speaker: Doctor M. Mano (Coimbra, PT)

Thumbnail

Access the full session

Cardiotoxicity, cardiac fibrosis and metabolic cardiomyopathy

Speakers: Doctor M. Panel, Assistant Professor V. Schwach, Doctor T. Gergely, Doctor M. Mano
Thumbnail

About the event

Image

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb